IMMUNOTHERAPY IN BREAST CANCER

Dr. Jain’s research focuses on immunotherapy as a complimentary approach for eliminating breast cancer. The success of many treatments, such as chemotherapy and targeted drugs, are limited by resistance and side effects. Her work centers on harnessing the body’s immune system to overcome these barriers.

This new approach, investigated as a Lynn Sage Scholar, entails a bacterial vaccine injected into a metastatic tumor, causing the tumor to deconstruct and generate an immune response to target and eliminate disseminated tumors throughout the body. After impressive results from animal trials, Dr. Jain studied this treatment in women with metastatic breast cancer. She collaborated with her basic science colleagues to improve upon the results and technology in the lab.

Dr. Jain received her medical degree from Southern Illinois University School of Medicine. She completed her internship and residency in internal medicine at the University of Michigan. She completed her fellowship in hematology and oncology at Weill Cornell Medical College, New York Presbyterian Hospital before joining Northwestern University Feinberg School of Medicine as an Assistant Professor of Medicine.